Inventor · disambiguated record
Wei-Jian Pan
Also filed as: PAN WEI · PAN WEI-JIAN
8 granted patents·21 pending applications·15 citations·filing 2011–2025
77Inventor score
Files withAMGEN INC9ALEXION PHARMA INC8UNIV PENNSYLVANIA4PAN WEI3CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2
Top patents by PatentIndex Score
29 records- 0195US10934336B2Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapyUNIV PENNSYLVANIA·Filed 2018·Granted Mar 2, 2021·12 cites·22 claims
- 0273US2025243264A1Dosage and administration of anti-c5 antibodies for treatment of generalized myasthenia gravisALEXION PHARMA INC·Filed 2024·Application pending·0 cites
- 0372US9914779B2Administration of alpha4beta7 hetero-dimer-specific antibodyAMGEN INC·Filed 2012·Granted Mar 13, 2018·3 cites·23 claims
- 0471US12227555B2Use of gene editing to generate universal TCR re-directed t cells for adoptive immunotherapyUNIV PENNSYLVANIA·Filed 2021·Granted Feb 18, 2025·0 cites·17 claims
- 0569US2025154223A1Use of gene editing to generate universal tcr re-directed t cells for adoptive immunotherapyUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 0668US2022135668A1Methods for Treating Psoriasis Using an Anti-IL-23 AntibodyAMGEN INC·Filed 2022·Application pending·0 cites
- 0767US2020283517A1Methods for treating chron's disease using an anti-il23 antibodyAMGEN INC·Filed 2020·Application pending·0 cites
- 0862US11993659B2BCMA targetting antibodies, chimeric antigen receptors, and uses thereofUTC THERAPEUTICS SHANGHAI CO LTD·Filed 2022·Granted May 28, 2024·0 cites·27 claims
- 0962US2020017581A1Methods for treating chron's disease using an anti-il23 antibodyAMGEN INC·Filed 2019·Application pending·0 cites
- 1058US2025154232A1Dosage and administration of anti-c5 antibodies for treatment of myasthenia gravisALEXION PHARMA INC·Filed 2022·Application pending·0 cites
- 1158US2016031983A1Methods for treating crohn's disease using an anti-il23 antibodyAMGEN INC·Filed 2014·Application pending·0 cites
- 1258US2021187054A1Efficacy of an anti-c5 antibody in the prevention of antibody mediated rejection in sensitized recipients of kidney transplantALEXION PHARMA INC·Filed 2020·Application pending·0 cites
- 1357US2018327490A1Methods for treating crohn's disease using an anti-il23 antibodyAMGEN INC·Filed 2017·Application pending·0 cites
- 1456US2017218062A1Methods for treating crohn's disease using an anti-il23 antibodyAMGEN INC·Filed 2017·Application pending·0 cites
- 1556US2020277368A1Methods for Treating Psoriasis Using an Anti-IL-23 AntibodyAMGEN INC·Filed 2019·Application pending·0 cites
- 1655US9564653B2Method for producing fuel cell including nanofibers of metal oxidePAN WEI·Filed 2015·Granted Feb 7, 2017·0 cites·8 claims
- 1755US2020331993A1Dosage and administration of anti-c5 antibodies for treatment of generalized myasthenia gravisALEXION PHARMA INC·Filed 2020·Application pending·0 cites
- 1855US2023121086A1RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOFSUNSHINE LAKE PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1954US2023067159A1Ror-gamma-t inhibitor, preparation method thereof and use thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2053US2013089485A1Nanofibers of metal oxide and production method thereforPAN WEI·Filed 2011·Application pending·0 cites
- 2149US2016060337A1Methods for treating psoriasis using an anti-il-23 antibodyAMGEN INC·Filed 2014·Application pending·0 cites
- 2249US2025082674A1Methods of treating copper metabolism-associated diseases or disordersALEXION PHARMA INC·Filed 2022·Application pending·0 cites
- 2348US9829463B2Method for producing oxygen sensorPAN WEI·Filed 2016·Granted Nov 28, 2017·0 cites·6 claims
- 2448US2024342127A1Methods of treating copper metabolism-associated diseases or disordersALEXION PHARMA INC·Filed 2022·Application pending·0 cites
- 2548US2022354889A1Dnmt3a knockout car t cells for adoptive immunotherapyUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2647US2022119431A1Salt of egfr inhibitor, crystal form, and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 2745US2018311299A1Efficacy of an anti-c5 antibody in the prevention of antibody mediated rejection in sensitized recipients of a kidney transplantALEXION PHARMA INC·Filed 2016·Application pending·0 cites
- 2843US11390625B2Aryl-phosphorus-oxygen compound as EGFR kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jul 19, 2022·0 cites·16 claims
- 2940US11224637B2Methods for treating hypophosphatasia (HPP) in adults and adolescentsALEXION PHARMA INC·Filed 2018·Granted Jan 18, 2022·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →